0001209191-18-041006.txt : 20180703 0001209191-18-041006.hdr.sgml : 20180703 20180703161645 ACCESSION NUMBER: 0001209191-18-041006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180629 FILED AS OF DATE: 20180703 DATE AS OF CHANGE: 20180703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 18937331 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-29 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Corp Controller Common Stock 2018-06-29 4 M 0 859 96.87 A 16946 D Common Stock 2018-06-29 4 S 0 859 171.87 D 16087 D Common Stock 2018-06-29 4 M 0 1289 91.05 A 17376 D Common Stock 2018-06-29 4 S 0 1289 166.05 D 16087 D Common Stock 2018-06-29 4 M 0 809 86.52 A 16896 D Common Stock 2018-06-29 4 S 0 809 161.57 D 16087 D Common Stock 169 I 401(k) Stock Option (Right to Buy) 96.87 2018-06-29 4 M 0 859 0.00 D 2024-07-14 Common Stock 859 860 D Stock Option (Right to Buy) 91.05 2018-06-29 4 M 0 1289 0.00 D 2026-02-01 Common Stock 1289 9024 D Stock Option (Right to Buy) 86.52 2018-06-29 4 M 0 809 0.00 D 2027-02-02 Common Stock 809 8899 D Transaction made pursuant to Mr. Silva's company-approved trading plan under Rule 10b5-1. The option vests in 16 quarterly installments from 07/15/2014. The option vests in 16 quarterly installments from 02/02/2016. The option vests in 16 quarterly installments from 02/03/2017. /s/ Stephen Migausky, Attorney-in-Fact 2018-07-03